Literature DB >> 3149211

In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.

Y Ogawa, H Okada, M Yamamoto, T Shimamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149211     DOI: 10.1248/cpb.36.2576

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  19 in total

Review 1.  Clinical pharmacokinetics of depot leuprorelin.

Authors:  Piero Periti; Teresita Mazzei; Enrico Mini
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Drug release from cast films of ethylene vinyl acetate (EVA) copolymer: Stability of drugs by 1H NMR and solid state 13C CP/MAS NMR.

Authors:  S Kalachandra; D M Lin; E O Stejskal; A Prakki; S Offenbacher
Journal:  J Mater Sci Mater Med       Date:  2005-07       Impact factor: 3.896

3.  Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate.

Authors:  H Okada; T Heya; Y Ogawa; H Toguchi; T Shimamoto
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

4.  A large-scale process to produce microencapsulated proteins.

Authors:  P Herbert; K Murphy; O Johnson; N Dong; W Jaworowicz; M A Tracy; J L Cleland; S D Putney
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

5.  The stabilization and encapsulation of human growth hormone into biodegradable microspheres.

Authors:  O L Johnson; W Jaworowicz; J L Cleland; L Bailey; M Charnis; E Duenas; C Wu; D Shepard; S Magil; T Last; A J Jones; S D Putney
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

6.  Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer.

Authors:  S Kalachandra; T Takamata; D M Lin; E A Snyder; J Webster-Cyriaque
Journal:  J Mater Sci Mater Med       Date:  2006-12       Impact factor: 3.896

7.  Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride.

Authors:  H Heiati; N C Phillips; R Tawashi
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

Review 8.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

9.  Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

Authors:  H Okada; Y Doken; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

10.  Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs.

Authors:  H Okada; Y Doken; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.